209 related articles for article (PubMed ID: 7236488)
1. Enhanced cell killing in lewis lung carcinoma and a human pancreatic-carcinoma xenograft by the combination of cytotoxic drugs and misonidazole.
Stephens TC; Courtenay VD; Mills J; Peacock JH; Rose CM; Spooner D
Br J Cancer; 1981 Apr; 43(4):451-7. PubMed ID: 7236488
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of cyclophosphamide cytotoxicity in vivo: a study with misonidazole and fifteen other 1-substituted 2-nitroimidazoles.
Chaplin DJ; Sheldon PW; Ahmed I; Adams GE
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1647-51. PubMed ID: 6480452
[TBL] [Abstract][Full Text] [Related]
3. The value of combining the radiosensitizer misonidazole with cyclophosphamide in treating the murine Lewis lung tumor.
Pedersen JE; Barron G; Meeker BE
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):651-3. PubMed ID: 7107392
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of cytotoxic drugs by misonidazole (MISO) in Lewis lung tumors of different sizes, and mouse bone marrow.
Spooner D; Peacock JH; Stephens TC
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):643-6. PubMed ID: 7107390
[TBL] [Abstract][Full Text] [Related]
5. Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU.
Twentyman P; Workman P
Br J Cancer; 1982 Mar; 45(3):447-55. PubMed ID: 7073938
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing the chemosensitization of melphalan by misonidazole.
Randhawa VS; Stewart FA; Denekamp J; Stratford MR
Br J Cancer; 1985 Feb; 51(2):219-28. PubMed ID: 3966979
[TBL] [Abstract][Full Text] [Related]
7. In vivo combination of misonidazole and the chemotherapeutic agent CCNU.
Siemann DW
Br J Cancer; 1981 Mar; 43(3):367-77. PubMed ID: 7225287
[TBL] [Abstract][Full Text] [Related]
8. The therapeutic potential of misonidazole enhancement of alkylating agent cytotoxicity.
Hirst DG; Brown JM
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):639-42. PubMed ID: 7107389
[TBL] [Abstract][Full Text] [Related]
9. Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.
Law MP; Hirst DG; Brown JM
Br J Cancer; 1981 Aug; 44(2):208-18. PubMed ID: 7272187
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of melphalan-induced tumour cell killing by misonidazole: an interaction of competing mechanisms.
Horsman MR; Evans JW; Brown JM
Br J Cancer; 1984 Sep; 50(3):305-16. PubMed ID: 6466544
[TBL] [Abstract][Full Text] [Related]
11. Chemosensitization of mouse tumors by misonidazole.
Randhawa VS; Stewart FA; Denekamp J
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):671-4. PubMed ID: 7107397
[TBL] [Abstract][Full Text] [Related]
12. Misonidazole enhancement of the action of BCNU and melphalan against human melanoma xenografts.
Clutterbuck RD; Millar JL; McElwain TJ
Am J Clin Oncol; 1982 Feb; 5(1):73-8. PubMed ID: 7081141
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazole.
McNally NJ; Hinchliffe M; de Ronde J
Br J Cancer; 1983 Aug; 48(2):271-8. PubMed ID: 6882665
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of the effect of cytotoxic drugs by radiosensitizers.
Martin WM; McNally NJ; De Ronde J
Br J Cancer; 1981 Jun; 43(6):756-66. PubMed ID: 7248157
[TBL] [Abstract][Full Text] [Related]
15. Nitrosourea-misonidazole combination chemotherapy: effect on KHT sarcomas, marrow stem cells and gut.
Mulcahy RT; Siemann DW; Sutherland RM
Br J Cancer; 1982 Jun; 45(6):835-42. PubMed ID: 6212075
[TBL] [Abstract][Full Text] [Related]
16. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
Siemann DW
Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the ability of some radiosensitizers undergoing clinical trials to act as chemosensitizers.
Hinchliffe M; McNally NJ
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1635-40. PubMed ID: 6237081
[TBL] [Abstract][Full Text] [Related]
18. Effect of clinical levels of misonidazole on the response of tumour and normal tissues in the mouse to alkylating agents.
Brown JM; Hirst DG
Br J Cancer; 1982 May; 45(5):700-8. PubMed ID: 7082556
[TBL] [Abstract][Full Text] [Related]
19. Distribution and tumour cytotoxicity of the radiosensitizer misonidazole (Ro-07-0582) in C57 mice.
Pedersen JE; Smith MR; Bugden RD; Peckham MJ
Br J Cancer; 1979 Apr; 39(4):429-33. PubMed ID: 444398
[TBL] [Abstract][Full Text] [Related]
20. Misonidazole and CCNU: further evidence for a pharmacokinetic mechanism of chemosensitization and therapeutic gain.
Lee FY; Workman P
Br J Cancer; 1984 May; 49(5):579-85. PubMed ID: 6722006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
